![]() |
| . |
Response Rate of AMORYN Users with Depression, Anxiety or Panic After Six Weeks Introduction Ultimately, real-world results matter most. In order to measure the real-world rate of response to supplementation with AMORYN, BioNeurix Corp. surveyed a random sample of individuals who had started using AMORYN approximately six to eight weeks prior. Our informal surveys demonstrate that AMORYN achieves an extraordinary success rate. After taking AMORYN for six weeks or more, over 80% of AMORYN users report positive results. Of users with depression, 90% reported that AMORYN reduced the severity of their depression. For those with anxiety, 88% reported a reduction in feelings of anxiety. For users with panic attacks, 88% told us they were having fewer panic attacks and 87% responded that any remaining panic attacks were less severe. Data Collection The results shown here were collected through informal surveys of AMORYN users. We randomly selected and e-mailed customers, all of which had purchased AMORYN between six and eight weeks prior, and requested that they participate in a brief survey about their experience with the supplement. Both individuals that were still using the supplement and those that had discontinued use for any reason (due to side effects, for instance) were included. The 66 AMORYN users that chose to participate completed a brief online questionnaire. The respondents were not compensated in any way, and the identities of the respondents were not revealed to the researchers compiling the data. The figures shown in the graphs below were compiled on April 25, 2005, and represent the results of the most recent survey. Past surveys involving a total of over 300 AMORYN users have produced consistent results. Please keep in mind that this data does not represent the results of a controlled clinical trial and should not be considered scientific proof of AMORYN's effectiveness. (For this, please review the clinical trials demonstrating the effectiveness of AMORYN's main ingredient.) This information is intended solely to give you a better idea of what current AMORYN users think about the supplement.
Fig. 1: Reported Effect of AMORYN on Severity of Various Negative Emotions
Fig. 2: Reported Overall Rating of Experience (Positive or Negative) with AMORYN After 6-8 Weeks
Fig. 3: User Opinions of AMORYN vs. Antidepressant Drugs
Fig. 4: User Opinions of AMORYN vs. other St. John's Wort Brands View Fig. 5: Side Effect Frequency and Severity As Reported by AMORYN Users in First 6-8 Weeks Discussion No single factor is wholly responsible for AMORYN's unsurpassed degree of real-world effectiveness. Rather, a number of considerations contribute to the consistently positive responses reported by AMORYN users: Conclusion The data shown above demonstrates that the vast majority of AMORYN users feel that the supplement has improved their mood and lessened feelings of depression and/or anxiety. These extraordinary success rates truly set AMORYN apart from the alternatives, making it a natural supplement that actually delivers on its promises. Although no therapy works for every individual, there's an excellent chance that you can benefit from AMORYN. Order today to experience the mood-elevating effects of AMORYN, the most effective supplement available for sustained emotional support. Further Reading Please read the testimonials to learn more about the specific benefits experienced by some of these individuals, or review the controlled clinical research demonstrating the effectiveness of hyperforin, the main ingredient. Otherwise, you can order now to begin experiencing the benefits of AMORYN for yourself. The terms "depression", "anxiety" and "panic" found above refer to common emotions, not medically-recognized psychiatric conditions. AMORYN should not be considered a treatment for major depressive disorder, generalized anxiety disorder, panic disorder, or any other disease. The information provided above is intended to illustrate the opinions of some AMORYN users and should not be considered scientifically-valid proof of AMORYN's therapeutic efficacy or used to guide medical treatment. Individual results will vary. |
![]() ![]() ![]() ![]() ![]() ![]() |
|